CATHY PAYNE: Open Payments
NPI 1285930925 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,790 in 67 payments from 31 companies in 2025. Trend: 2023 $2,750 · 2024 $2,508 · 2025 $1,790
Food & beverage: $1,691Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $168 |
| E.R. Squibb & Sons, L.L.C. | 7 | $166 |
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| ABBVIE INC. | 9 | $135 |
| Amgen Inc. | 1 | $121 |
| Incyte Corporation | 2 | $120 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Syndax Pharmaceuticals, Inc. | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Sumitomo Pharma America, Inc. | 1 | $60 |
Products named: KYPROLIS, OPDIVO, EPKINLY, KEYTRUDA, ENHERTU, RYBREVANT, ORGOVYX, CARVYKTI.
Industry payments across AZ — which companies pay providers there.
